Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hetrombopag in the Treatment of Thrombocytopenia Induced by Gynecological Tumor Therapy
NCT07408648Phase 2Not yet recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Apr 2026
- Primary completion
- Apr 2027
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of hetrombopag in chemotherapy-induced thrombocytopenia (CIT), sponsored by Sun Yat-sen Memorial Hospital. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
hetrombopag
03
Conditions
chemotherapy-induced thrombocytopenia (CIT)
Beyond the preview
Go deeper on NCT07408648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07408648.